NASDAQ:SLP - Simulations Plus Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $64.50
  • Forecasted Upside: 39.94 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$46.09
▲ +0.05 (0.11%)

This chart shows the closing price for SLP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Simulations Plus Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SLP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SLP

Analyst Price Target is $64.50
▲ +39.94% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Simulations Plus in the last 3 months. The average price target is $64.50, with a high forecast of $76.00 and a low forecast of $53.00. The average price target represents a 39.94% upside from the last price of $46.09.

This chart shows the closing price for SLP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Simulations Plus. This rating has held steady since September 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/3/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/30/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/29/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/26/2021Craig HallumUpgradeHold ➝ Buy$65.00 ➝ $53.00High
7/13/2021OppenheimerReiterated RatingBuy$75.00High
7/13/2021Craig HallumLower Price TargetHold$74.00 ➝ $65.00High
7/13/2021Raymond JamesLower Price TargetOutperform$95.00 ➝ $54.00High
4/13/2021Craig HallumLower Price TargetHold$81.00 ➝ $74.00High
1/12/2021OppenheimerBoost Price Target$79.00 ➝ $85.00High
1/12/2021Craig HallumDowngradeBuy ➝ HoldHigh
11/25/2020Taglich BrothersUpgradeSpeculative Buy ➝ Buy$76.00High
11/17/2020Craig HallumBoost Price TargetBuy$75.00 ➝ $81.00High
10/16/2020Raymond JamesInitiated CoverageOutperform$95.00Low
9/8/2020OppenheimerInitiated CoverageOutperform$79.00High
7/10/2020Craig HallumBoost Price TargetBuy$56.00 ➝ $75.00High
6/8/2020Craig HallumBoost Price TargetBuy$40.00 ➝ $56.00Low
1/6/2020Craig HallumInitiated CoverageBuy$40.00High
1/16/2019Taglich BrothersDowngradeBuy ➝ Speculative BuyMedium
(Data available from 10/27/2016 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/31/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2021
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/29/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2021
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2021
  • 4 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
10/27/2021

Current Sentiment

  • 4 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Simulations Plus logo
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It operates through the following segments: Simulations Plus, Inc., Cognigen Corporation, DILIsym, and Lixoft. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
Read More

Today's Range

Now: $46.09
Low: $44.09
High: $46.46

50 Day Range

MA: $42.54
Low: $37.10
High: $47.98

52 Week Range

Now: $46.09
Low: $36.90
High: $90.92

Volume

208,510 shs

Average Volume

172,097 shs

Market Capitalization

$927.93 million

P/E Ratio

82.30

Dividend Yield

0.52%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Simulations Plus?

The following equities research analysts have issued stock ratings on Simulations Plus in the last twelve months: Craig Hallum, Oppenheimer Holdings Inc., Raymond James, Taglich Brothers, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for SLP.

What is the current price target for Simulations Plus?

4 Wall Street analysts have set twelve-month price targets for Simulations Plus in the last year. Their average twelve-month price target is $64.50, suggesting a possible upside of 41.2%. Taglich Brothers has the highest price target set, predicting SLP will reach $76.00 in the next twelve months. Craig Hallum has the lowest price target set, forecasting a price of $53.00 for Simulations Plus in the next year.
View the latest price targets for SLP.

What is the current consensus analyst rating for Simulations Plus?

Simulations Plus currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SLP will outperform the market and that investors should add to their positions of Simulations Plus.
View the latest ratings for SLP.

What other companies compete with Simulations Plus?

How do I contact Simulations Plus' investor relations team?

Simulations Plus' physical mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company's listed phone number is (661) 723-7723 and its investor relations email address is [email protected] The official website for Simulations Plus is www.simulations-plus.com.